These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 17381489)

  • 1. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of bone turnover markers and bone mineral density to growth hormone therapy in children with isolated growth hormone deficiency and multiple pituitary hormone deficiencies.
    Kandemir N; Gonc EN; Yordam N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):809-16. PubMed ID: 12099391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency.
    Bozzola M; Adamsbaum C; Biscaldi I; Zecca M; Cisternino M; Genovese E; Richard I; Kalifa G; Chaussain JL
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):21-6. PubMed ID: 8796134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF; Jensen JE; Eskildsen PC
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
    de Boer H; Blok GJ; Popp-Snijders C; Sips A; Lips P; van der Veen E
    J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency.
    Benbassat CA; Wasserman M; Laron Z
    Growth Horm IGF Res; 1999 Oct; 9(5):290-5. PubMed ID: 10543936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent treatment with human growth hormone (GH) in isolated GH deficiency and in multiple pituitary hormone deficiencies.
    Pertzelan A; Kauli R; Assa S; Greenberg D; Laron Z
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):15-24. PubMed ID: 1248156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.
    Bravenboer N; Holzmann PJ; ter Maaten JC; Stuurman LM; Roos JC; Lips P
    J Bone Miner Res; 2005 Oct; 20(10):1778-84. PubMed ID: 16160735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years.
    Bechtold S; Ripperger P; Bonfig W; Schmidt H; Bitterling H; Häfner R; Schwarz HP
    J Rheumatol; 2004 Jul; 31(7):1407-12. PubMed ID: 15229964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.
    Yordam N; Kandemir N; Alikaşifoğlu A
    Turk J Pediatr; 1998; 40(1):55-60. PubMed ID: 9673529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.